Connect with us

Hi, what are you looking for?

Stock

GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines

Published

(Reuters) – GlaxoSmithKline (NYSE:GSK) sued Moderna (NASDAQ:MRNA) in Delaware federal court on Tuesday for allegedly violating GSK’s patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax.

The lawsuit said Moderna’s lipid nanoparticles for transporting mRNA into the human body infringe several GSK patents covering similar innovations. GSK filed a related lawsuit against Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) in the same court in April over their COVID-19 vaccines.

This post appeared first on investing.com

In this article:






    You May Also Like

    Editor's Pick

    How voters view Vance and Walz, in detail

    Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

    October 1, 2024

    Latest News

    A North Korean defector who struggled in South Korea stole a bus and tried to drive across the border, police say

    A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

    October 3, 2024

    Economy

    Hamas leader killed in Lebanon was UN employee, agency confirms

    A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

    September 30, 2024

    Investing

    Astron, Energy Fuels Form Joint Venture for Donald Rare Earths and Mineral Sands Project

    Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

    September 27, 2024

    Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 balanceandcharge.com